Chemical inhibitors of BC002199 can affect the protein's activity through various modes of action. Staurosporine, a broad-spectrum kinase inhibitor, blocks the ATP binding site of BC002199, which is essential for its kinase activity. This prevents BC002199 from phosphorylating its substrates, effectively shutting down its catalytic function. Similarly, Bisindolylmaleimide I targets protein kinase C (PKC), and if BC002199's activity is regulated by or involves PKC in its pathway, Bisindolylmaleimide I's action would result in BC002199 inhibition by preventing PKC-mediated activation or phosphorylation of BC002199.
Rapamycin, which specifically targets mTOR kinase, and LY294002, a PI3K inhibitor, can inhibit BC002199 indirectly by acting upstream within the same pathway. If BC002199 operates downstream of mTOR or PI3K, these inhibitors would block the activation signals that BC002199 requires for its function. Wortmannin, another PI3K inhibitor, also acts covalently to inhibit PI3K, which can lead to the inhibition of BC002199 if it is downstream of this pathway. In the MAPK/ERK pathway, PD98059 and U0126, both MEK inhibitors, prevent the activation of kinases downstream of MEK, including BC002199 if it is part of this signaling cascade. SB203580, which selectively inhibits p38 MAP kinase, and SP600125, a JNK pathway inhibitor, work in a similar fashion by targeting kinases upstream of BC002199, leading to its functional inhibition if it is reliant on these pathways for activation. Additionally, the tyrosine kinase inhibitors Imatinib and Gefitinib, which target Bcr-Abl/c-Kit and EGFR respectively, can decrease the activity of BC002199 by inhibiting upstream kinases that regulate BC002199. Lastly, Triciribine, by specifically inhibiting Akt kinase, can suppress the activity of BC002199 if its function is controlled by the PI3K/Akt signaling axis. Each inhibitor, by targeting specific kinases or pathways, can modulate the activity of BC002199 depending on its position and role within these cellular signaling networks.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits Akt, a serine/threonine kinase involved in the PI3K/Akt pathway. If BC002199's function is regulated by or dependent on Akt signaling, triciribine's inhibition of Akt would result in the functional inhibition of BC002199. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a potent and selective inhibitor of protein kinase C (PKC). If BC002199 is a kinase that is activated by PKC or is part of a pathway involving PKC, the inhibition of PKC by Bisindolylmaleimide I would lead to the functional inhibition of BC002199 by preventing its activation or the phosphorylation events it mediates. | ||||||